Scor


08/05/25 -"We have updated our model to reflect Scor’s 1Q25 results and revised our assumptions for FY25 and beyond. The results were well ahead of expectations across both Life & Health and P&C, despite ..."

Pages
59
Language
English
Published on
08/05/25
You may also be interested by these reports :
18/03/26
Talanx has released its final FY25 results. As a reminder, the preliminary results had already been published in February, while Hannover Re reported ...

17/03/26
Hannover Re’s 4Q25 results demonstrate the group’s ability to navigate a more challenging P&C market, with continued strong top-line growth and ...

16/03/26
We have incorporated Uniqa’s recently published FY25 results into our model and reviewed our assumptions for subsequent years. The FY25 net result ...

16/03/26
UNIQA reported strong results for FY25, although Q4 trends were more mixed – partly due to exceptional items and a prudent reserving approach in an ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO